IGF-1 LR3
Growth Factor Peptide - Long-arginine IGF-1 analog studied for cellular growth signalling.
IGF-1 LR3 is a modified analog of insulin-like growth factor 1 with an extended half-life, studied for its role in cellular growth and proliferation research.
IGF-1 LR3 is an engineered analog with reduced binding-protein affinity and a longer half-life, giving researchers a more persistent IGF-1 signal than the native growth factor. It is studied for cellular growth and proliferation endpoints in vitro.
IGF-1 LR3 specifications
- Sequence
- Long R3 insulin-like growth factor 1
- Presentation
- Lyophilised powder
- Documented purity
- 99.67% by HPLC
- Available sizes
- 1mg ($70)
- Archived COA lots
- 1
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- IGF-1 receptor - Long-acting analog studied for sustained IGF-1-receptor activation.
Reported mechanisms in the literature
- IGF-1 receptor - A long-arginine analog of insulin-like growth factor 1 with an extended half-life, studied for sustained IGF-1-receptor activation and cellular growth signalling. (Preclinical literature)
IGF-1 LR3 frequently asked questions
What is IGF-1 LR3?
A modified analog of insulin-like growth factor 1 with an extended half-life, studied for cellular growth, proliferation and anabolic signalling.
Is it approved for human use?
No. It is a research material only, with preclinical data. It is not a medicine or supplement.
What is it researched for?
Sustained IGF-1-receptor activation and its downstream growth/proliferation signalling in cell models.
Documented to 99.67% purity by HPLC · third-party COA every lot · from $70 · For laboratory research use only.
Related Growth Hormone compounds
- Tesamorelin - GHRH analog studied for growth-hormone-axis research.
- Ipamorelin - Selective GH secretagogue studied for receptor-selective GH release.
- CJC-1295 - GHRH analog studied for sustained GH signalling.